Senior insider sale
Chief Financial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$1.79M
53.12K shares
What this filing means
GRUBER JAMES R. plans to sell 53.12K shares of ETON PHARMACEUTICALS, INC. valued at approximately $1.79M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001974078-26-000255
Officer· Chief Financial Officer
Since Apr 2022
53.12K
Shares to sell
$1.79M
Approx. market value
25K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/25/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Stock Option Exercise Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
25K
Market value
$831.7K
6/23/2026
—Completed
Units to sell
3.12K
Market value
$84.0K
6/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
25K
Market value
$875.3K
6/25/2026
Total
Units
53.12K
Value
$1.79M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/23/2026 | 25K | $831.7K | — | Completed |
6/2/2026 | 3.12K | $84.0K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2026 | 25K | $875.3K | Nasdaq | Planned |
| Total | 53.12K | $1.79M | ||